Antiplatelet monotherapy after DAPT: is clopidogrel the new standard? Pros and cons

Hyo Soo Kim, Jeehoon Kang, Giulio Stefanini, Raffaele De Caterina

Research output: Contribution to journal › Comment/debate

Access to Document

@article{d1e39710784f416899781e1b4124b88c,

title = "Antiplatelet monotherapy after DAPT: is clopidogrel the new standard? Pros and cons",

author = "Kim, {Hyo Soo} and Jeehoon Kang and Giulio Stefanini and {De Caterina}, Raffaele",

year = "2024",

month = jun,

day = "17",

doi = "10.4244/EIJ-E-24-00009",

language = "English",

volume = "20",

pages = "e737--e739",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "Europa Group",

number = "12",

}

TY - JOUR

T1 - Antiplatelet monotherapy after DAPT

T2 - is clopidogrel the new standard? Pros and cons

AU - Kim, Hyo Soo

AU - Kang, Jeehoon

AU - Stefanini, Giulio

AU - De Caterina, Raffaele

PY - 2024/6/17

Y1 - 2024/6/17

UR - http://www.scopus.com/inward/record.url?scp=85196529035&partnerID=8YFLogxK

U2 - 10.4244/EIJ-E-24-00009

DO - 10.4244/EIJ-E-24-00009

M3 - Comment/debate

C2 - 38887879

AN - SCOPUS:85196529035

SN - 1774-024X

VL - 20

SP - e737-e739

JO - EuroIntervention

JF - EuroIntervention

IS - 12

ER -